Structure Info
- Chemspace ID
- CSCS14929135734 (Synthesis)
- IUPAC Name
- N-(3-chloro-2-fluorophenyl)-7-methoxy-6-{2-[(4-methylpiperazin-1-yl)oxy]ethoxy}quinazolin-4-amine
- Mol formula
- C22H25ClFN5O3
- Mol weight
- 462 Da
- Catalog Number(s)
- HY-149695
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.37
- Heavy atoms count
- 32
- Rotatable bond count
- 8
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.363
- Polar surface area (Å)
- 72
- Hydrogen bond acceptors count
- 8
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSCS14929135734
Items Overall 2 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| MedChemExpress | TBD | United States To: | 90 | 1 mg | POA | |
Description: Names: EGFR-IN-91; Product Description: EGFR-IN-91 (compound 9) is an orally available EGFR inhibitor with blood-brain barrier penetrability. EGFR-IN-91 inhibits EGFR L858R/C797S and EGFR exon 19del/C797S , inducing tumor regression in xenograft (PDX) mouse models. EGFR-IN-91 has the potential to inhibit localized and metastatic non-small cell lung cancer (NSCLC) driven by EGFR mutants .; Target: EGFR; CAS: 3032113-20-2 | ||||||
| MedChemExpress EU | TBD | Sweden To: | 90 | 1 mg | POA | |
Description: Names: EGFR-IN-91; Product Description: EGFR-IN-91 (compound 9) is an orally available EGFR inhibitor with blood-brain barrier penetrability. EGFR-IN-91 inhibits EGFRL858R/C797S and EGFRexon 19del/C797S, inducing tumor regression in xenograft (PDX) mouse models. EGFR-IN-91 has the potential to inhibit localized and metastatic non-small cell lung cancer (NSCLC) driven by EGFR mutants; Target: EGFR; CAS: 3032113-20-2 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire